title: Recombinant interleukin-2 in the treatment of refractory solid tumors in pediatric oncology patients: nursing implications.
authors.forename: B
authors.initials: B
authors.lastname: Taylor
authors.forename: K
authors.initials: K
authors.lastname: Scarbrough
authors.forename: G
authors.initials: G
authors.lastname: Simpson
authors.forename: R
authors.initials: R
authors.lastname: Giometti
authors.forename: M
authors.initials: M
authors.lastname: Turnage
authors.forename: J
authors.initials: J
authors.lastname: Turner
authors.forename: L
authors.initials: L
authors.lastname: Oakes
authors.forename: B
authors.initials: B
authors.lastname: Steen
authors.forename: M
authors.initials: M
authors.lastname: Bledsoe
mesh_terms: D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009369:Neoplasms / Q000451:nursing / Q000628:therapy*
chemical_list: D007376:Interleukin-2